Literature DB >> 11104157

The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.

M M Schwartz1.   

Abstract

The podocyte has diverse functions including glomerular filtration, biosynthesis and maintenance of the glomerular capillary architecture. It discharges these functions by virtue of a unique morphology, an intimate relationship with the capillary wall, and diverse synthetic and membrane specializations. Despite the complex role that it plays in glomerular function, the clinical manifestations of podocyte dysfunction are limited to proteinuria and renal insufficiency. Recurrent focal segmental glomerulosclerosis (FSGS) in renal transplants provides a unique opportunity to study the pathogenesis of FSGS in human beings, because the patients are monitored carefully to identify the onset of disease, the recurrence is presumed to have the same etiology as the primary disease, renal biopsy is a tool to study the pathogenesis of the lesion, and therapeutic intervention provides a mechanism to test pathogenesis. Pathologic studies have identified a proliferative lesion of the podocytes as the first sign of recurrent disease. The glomerular lesions evolve to form segmental glomerular scars with time. These findings and studies in experimental models of FSGS implicate podocyte injury in the pathogenesis of the recurrent disease. The cellular lesion (similar to the proliferative lesion of podocytes in recurrent FSGS), seen early in the course of primary FSGS suggests that the pathogenic sequence in recurrent FSGS also applies to primary FSGS. A soluble circulating factor that increases glomerular permeability and correlates with recurrence of FSGS has been identified in the pretransplant serum of patients with end-stage FSGS, but the mechanism of podocyte injury by this factor remains speculative. In any case, podocytes in the cellular lesion undergo morphologic changes and lose specialized functions seen in the normal mature cell, and these structural and functional abnormalities cause the permeability changes associated with proteinuria and destruction of glomerular filtration surface by scarring associated with loss of glomerular function.

Entities:  

Mesh:

Year:  2000        PMID: 11104157     DOI: 10.1081/jdi-100101955

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  9 in total

Review 1.  What has the immune system got against the glomerular podocyte?

Authors:  P W Mathieson
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

2.  Costimulatory blockade: A novel approach to the treatment of glomerular disease?

Authors:  Pasquale Esposito; Teresa Rampino; Antonio Dal Canton
Journal:  World J Methodol       Date:  2015-06-26

3.  Recurrent focal segmental glomerulosclerosis after kidney transplantation.

Authors:  Rebecca Trachtman; Simranjeet S Sran; Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2015-02-19       Impact factor: 3.714

4.  Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan.

Authors:  Yu-Huei Liu; Cheng-Hsu Chen; Shih-Yin Chen; Ying-Ju Lin; Wen-Ling Liao; Chang-Hai Tsai; Lei Wan; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2010-10-11       Impact factor: 8.410

5.  Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro.

Authors:  Masaru Motojima; Taiji Matsusaka; Valentina Kon; Iekuni Ichikawa
Journal:  Nephron Exp Nephrol       Date:  2009-11-03

6.  Epidermal growth factor activates Na(+/)H(+) exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin.

Authors:  Sonya D Coaxum; Maria N Garnovskaya; Monika Gooz; Aleksander Baldys; John R Raymond
Journal:  Biochim Biophys Acta       Date:  2009-03-31

7.  Characterization of a Trpc6 Transgenic Mouse Associated with Early Onset FSGS.

Authors:  Cesar P Canales; Paola Krall; Pamela Kairath; Irene C Perez; Miryam A Fragoso; Paulina Carmona-Mora; Phillip Ruiz; Jochen Reiser; Juan I Young; Katherina Walz
Journal:  Br J Med Med Res       Date:  2014-10-30

8.  Alendronate-associated focal segmental glomerulosclerosis.

Authors:  Marios Prikis; Pamela C Gibson; Wolfgang J Weise
Journal:  NDT Plus       Date:  2009-02

9.  WWC1 promotes podocyte survival via stabilizing slit diaphragm protein dendrin.

Authors:  Ting Lin; Li Zhang; Shuangxin Liu; Yuanhan Chen; Hong Zhang; Xingchen Zhao; Ruizhao Li; Qianmei Zhang; Ruyi Liao; Zongshun Huang; Bin Zhang; Wenjian Wang; Xinling Liang; Wei Shi
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.